OAC’s Work on GLP-1 Compounding: Advocating for Safety and Access
in OAC Blog on November 19, 2024

The conversation around GLP-1 medications has grown louder in recent years, with these treatments showing great promise for managing obesity. However, challenges like supply shortages and affordability have created barriers for many individuals. In response, patients are turning to compounded GLP-1 medications as an alternative. Leading Conversations on GLP-1 Compounding At the Obesity Action Coalition
Read Article